The Patent Finder

Solasia Pharma K.K.

Also on record
Records under this name other than the patents Solasia Pharma K.K. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 5 of 5 · Back to Solasia Pharma K.K.

PatentTitleStatus Expires Confidence
US 7,968,738Compounds and methods for the treatment of cancer
Term ended
Term ended Jul 28, 2026 · From the USPTO record
Term endedTerm ended Jul 28, 2026From the USPTO record
US 8,334,398Compounds and methods for the treatment of cancer
Term ended
Term ended Jul 28, 2026 · From the USPTO record
Term endedTerm ended Jul 28, 2026From the USPTO record
US 8,865,764Compounds and methods for the treatment of cancer
Term ended
Term ended Jul 28, 2026 · From the USPTO record
Term endedTerm ended Jul 28, 2026From the USPTO record
US 8,796,329Method for controlling angiogenesis in animals
Lapsed on the fee record
Ended Aug 5, 2022 · From the USPTO record
Lapsed on the fee recordEnded Aug 5, 2022From the USPTO record
US 8,252,773Combination therapy with organic arsenicals
Lapsed on the fee record
Ended Aug 28, 2016 · From the USPTO record
Lapsed on the fee recordEnded Aug 28, 2016From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited